Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for AbbVie Inc. and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
ABBV · NYSE · ·
Next earnings: October 30, 2026
$263.28-1.2%Sep 29 close
AbbVie researches, develops and sells medicines and aesthetic treatments for immune diseases, neurological conditions, cancers and other health needs.